BioMérieux reported today that its fourth quarter revenues rose 11 percent year over year driven by sales of molecular biology reagents and microbiology instruments, as well as a strong dynamic in Asia Pacific.... Read More >

Adaptive Biotechnologies reported after the close of the market on Wednesday that its fourth quarter revenues increased 41 percent year over year.... Read More >

Lucid Diagnostics announced recently it has entered a research agreement with the Fred Hutchinson Cancer Research Center to evaluate the center's Barrett's Esophagus progression biomarkers using Lucid's EsoCheck Esophageal Cell Collection De... Read More >

Novacyt said recently that its molecular test for the COVID-19 virus has received CE marking. Read More >

10x Genomics reported after the close of the market recently a 49 percent increase in fourth quarter revenues driven by consumables sales. Read More >

Agilent Technologies reported after the close of the market recently that its fiscal first quarter revenues rose 6 percent year over year. Read More >

Invitae reported after the close of the market recently that its fourth quarter 2019 revenues increased 47 percent from the prior year. Read More >

Diagnostics manufacturer Quidel reported after the close of the market recently that its fourth quarter revenues rose 15 percent year over year, due primarily to growth in its rapid immunoassay business.... Read More >

Foundation Medicine and Chugai Pharmaceutical said recently they have entered into an agreement with the National Cancer Center Japan to use Foundation's liquid biopsy test as part of an initiative targeting advanced cancer patients.... Read More >

Bio-Rad Laboratories said after the close of the market recently that its fourth quarter revenues rose approximately 1 percent year over year.... Read More >